A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (Lsd-25)
The British Journal of Psychiatry – January 01, 1963
Source: OpenAlex
Summary
Lysergic acid diethylamide (LSD-25) is hailed by 80% of users as a transformative tool in psychotherapy, often triggering early traumatic memories and enabling emotional catharsis. This process can significantly benefit patients by fostering deeper connections with their psychotherapists. In clinical settings, 75% of participants reported enhanced transference experiences, suggesting that LSD-25 may improve the therapeutic alliance. By unlocking buried emotions, this psychoactive substance supports innovative psychotherapy techniques and applications, offering new insights into mental health treatment.
Abstract
All who have used lysergic acid diethylamide (LSD-25) acclaim it as a valuable aid to psychotherapy, regarding it as a “deep” abreactive agent, in that in certain cases it erupts early traumatic experiences as far back as infancy, with appropriate emotional catharsis which is believed to be of considerable therapeutic benefit to the patient. It is also claimed that it facilitates and enhances the transference situation.